Cardinal Health Reports Fourth Quarter and Full Year Results for Fiscal Year 2022

Go back to Cardinal Health Reports Fourth Quarter and Full Year Results for Fiscal Year 2022

Cardinal Health (CAH) PT Raised to $72 at Deutsche Bank

August 15, 2022 7:41 PM EDT

Deutsche Bank analyst George Hill raised the price target on Cardinal Health (NYSE: CAH) to $72.00 (from $69.00) while maintaining a Hold rating.

... More

Cardinal Health (CAH) Misses Q4 EPS by 12c, Offers Guidance

August 11, 2022 6:55 AM EDT

Cardinal Health (NYSE: CAH) reported Q4 EPS of $1.05, $0.12 worse than the analyst estimate of $1.17. Revenue for the quarter came in at $47.1 billion versus the consensus estimate of $44.75 billion.

GUIDANCE:

Cardinal Health sees FY2023 EPS of $5.05-$5.40, versus the consensus of... More